(Q36128969)

12 August 2017

1 reference

title

Risk assessment of chemicals and pharmaceuticals in the pediatric population: a workshop report (English)

1 reference

12 August 2017

0 references

Pohl HR

1

1 reference

12 August 2017

van Engelen JG

series ordinal

2

1 reference

12 August 2017

Wilson J

series ordinal

3

1 reference

12 August 2017

Sips AJ

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

2 March 2005

1 reference

Regulatory Toxicology and Pharmacology

12 August 2017

published in

1 reference

12 August 2017

volume

42

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

83-95

1 reference

Breast-feeding exposure of infants to cadmium, lead, and mercury: a public health viewpoint

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Applying Simulation Modeling to Problems in Toxicology and Risk Assessment: A Short Perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Tissue dosimetry, pharmacokinetic modeling, and interspecies scaling factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Biological factors which may influence an older child's or adolescent's responses to toxic chemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Differences in sensitivity of children and adults to chemical toxicity: the NAS panel report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Addressing human variability in risk assessment--the robustness of the intraspecies uncertainty factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Lactational transfer of tetrachloroethylene in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Testing methods for developmental neurotoxicity of environmental chemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Risk assessment extrapolations and physiological modeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Biologically motivated models for chemical risk assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Use of physiologically based pharmacokinetic modeling to investigate individual versus population risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Development of a physiologically based pharmacokinetic model for chloroform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

A framework for assessing risks to children from exposure to environmental agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Role of biokinetics in risk assessment of drugs and chemicals in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Differential sensitivity of children and adults to chemical toxicity. II. Risk and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Altered behaviour in adult mice exposed to a single low dose of DDT and its fatty acid conjugate as neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: examples with warfarin and parathion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Neoplastic and nonneoplastic lesions in aging Osborne-Mendel rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Characterization of age-related changes in body weight and organ weights from birth to adolescence in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Differences in pharmacokinetics between children and adults--II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Physiologically based pharmacokinetic and pharmacodynamic modeling in health risk assessment and characterization of hazardous substances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Proteomic approaches to characterize protein modifications: new tools to study the effects of environmental exposures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Clinical use of the Medication Event Monitoring System: a new window into pediatric compliance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Drug compliance in pediatrics. Clinical and research issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Noncompliance and treatment failure in children with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Hazard identification and predictability of children's health risk from animal data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Assessment of risk from multimedia exposures of children to environmental chemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Physiologically based models for bone-seeking elements. IV. Kinetics of lead disposition in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

PBK modeling for metals. Examples with lead, uranium, and chromium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Workshop to develop a framework for assessing risks to children from exposure to environmental agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Utilizing uncertainty factors in minimal risk levels derivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Breast-feeding exposure of infants to environmental contaminants--a public health risk assessment viewpoint: chlorinated dibenzodioxins and chlorinated dibenzofurans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Breast-feeding exposure of infants to selected pesticides: a public health viewpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Evaluating lead bioavailability data by means of a physiologically based lead kinetic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Critical windows of exposure for children's health: the reproductive system in animals and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Differential sensitivity of children and adults to chemical toxicity. I. Biological basis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

Burden of disease attributable to selected environmental factors and injury among children and adolescents in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2005.01.005

10.1016/J.YRTPH.2005.01.005

7 January 2021

Identifiers

DOI

1 reference

12 August 2017

1 reference